e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Outcomes and new treatment strategies in pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry
A. Boucly (PARIS, France)
Source:
International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Session:
Outcomes and new treatment strategies in pulmonary hypertension
Session type:
Poster Discussion
Number:
3527
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Boucly (PARIS, France). Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry. 3527
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Source: Eur Respir J 2015; 46: 903-975
Year: 2015
Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry
Source: Breathe, 14 (2) 93; 10.1183/20734735.002018
Year: 2018
Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly.
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020
Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK)
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Risk assessment in Pulmonary Arterial Hypertension (PAH) based on the Simplified French Model: A single centre experience
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model
Source: Eur Respir J 2016; 48: 780-786
Year: 2016
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
Year: 2018
Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration
Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020
Year: 2020
Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Guideline 2019
Year: 2019
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
Source: Eur Respir J, 54 (3) 1901647; 10.1183/13993003.01647-2019
Year: 2019
Screening for COPD using the Canadian Lung Association questionnaire: A practice assessment of Canadian physicians
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
The OPTIEK1 study: Design and preliminary results of a Dutch national registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit
Source: International Congress 2017 – COPD management
Year: 2017
Longitudinal data-driven definition of clinical asthma phenotypes in the pediatric arm of the All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL)
Source: Virtual Congress 2020 – Hot topics in paediatric asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept